Male Breast Cancer Withdrawn Phase Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01939483A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS MetastasesTreatment